Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132259) titled 'The impact of brain CTA on intraoperative blood loss, pathological findings, and prognosis in patients with meningioma' on Sept. 11.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Meningioma
Intervention:
CTA Group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-08-10
Target Sample Size: CTA Group:500;No CTA group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=246927
Disclaimer: Curated by HT Syndication....